Published in Br J Pharmacol on April 01, 1971
Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. Br J Pharmacol (1972) 4.45
Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings]. Br J Pharmacol (1977) 3.51
Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol (2006) 2.60
Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc Natl Acad Sci U S A (2000) 2.27
Fine structure of the myenteric plexus in the guinea-pig ileum. J Anat (1972) 2.14
A molecular description of nerve terminal function. Annu Rev Biochem (1983) 1.82
Dopamine transporter site-directed mutations differentially alter substrate transport and cocaine binding. Proc Natl Acad Sci U S A (1992) 1.79
Neurotransmitter transporters and their impact on the development of psychopharmacology. Br J Pharmacol (2006) 1.77
Combined alpha- and beta-adrenoceptor blocking drug AH 5158: further studies on alpha-adrenoceptor blockade in anaesthetized animals. Br J Pharmacol (1975) 1.72
An electrophysiological analysis of the effects of amine-uptake blockers and alpha-adrenoceptor blockers on adrenergic neuromuscular transmission. Br J Pharmacol (1975) 1.54
The reverse operation of Na(+)/Cl(-)-coupled neurotransmitter transporters--why amphetamines take two to tango. J Neurochem (2009) 1.36
Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3. J Pharmacol Exp Ther (2010) 1.34
Regulation of monoamine transporters: Role of transporter phosphorylation. Pharmacol Ther (2010) 1.30
Expression and immunolocalization of the plasma membrane monoamine transporter in the brain. Neuroscience (2007) 1.30
Neurotransmitter and psychostimulant recognition by the dopamine transporter. Nature (2015) 1.30
Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis. J Neurosci (2010) 1.25
Factors affecting the extraneuronal inactivation of noradrenaline in cardiac and smooth muscle. Br J Pharmacol (1972) 1.22
Ca(2+)/calmodulin-dependent protein kinase IIα (αCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome. J Biol Chem (2012) 1.14
Effects of antidepressant drugs on noradrenaline accumulation and contractile responses in the rat anococcygeus muscle. Br J Pharmacol (1977) 1.10
Ionic currents in the human serotonin transporter reveal inconsistencies in the alternating access hypothesis. Biophys J (2003) 1.10
The purinergic neurotransmitter revisited: a single substance or multiple players? Pharmacol Ther (2014) 1.06
Inhibitory synaptic potentials recorded from mammalian neurones prolonged by blockade of noradrenaline uptake. J Physiol (1987) 1.06
Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atria. Br J Pharmacol (1973) 1.03
Co-release of acetylcholine and gamma-aminobutyric acid by a retinal neuron. Proc Natl Acad Sci U S A (1989) 1.01
Insights into transport mechanism from LeuT engineered to transport tryptophan. EMBO J (2011) 1.00
The effects of pargyline on overflow of transmitter and uptake of noradrenaline in the cat spleen. Br J Pharmacol (1973) 1.00
Subcellular localization of the antidepressant-sensitive norepinephrine transporter. BMC Neurosci (2009) 1.00
Structure-activity relations for the inhibition of catecholamine uptake into synaptosomes from noradrenaline and dopaminergic neurones in rat brain homogenates. Br J Pharmacol (1973) 0.96
Flux coupling in the human serotonin transporter. Biophys J (2002) 0.95
Stimulus-secretion coupling processes in brain: analysis of noradrenaline and gamma-aminobutyric acid release. J Physiol (1976) 0.93
Effects of the inhibition of noradrenaline uptake and synthesis on the maintenance of the response to continuous nerve stimulation in the central artery of the rabbit ear. Br J Pharmacol (1972) 0.92
Mechanisms by which human blood platelets accumulate glycine, gaba and amino acid precursors of putative neurotransmitters. Br J Pharmacol (1972) 0.92
Involvement of uptake2 in the termination of activity of neurogenic noradrenaline in the rat isolated atrium. J Physiol (1976) 0.92
Rab11 supports amphetamine-stimulated norepinephrine transporter trafficking. J Neurosci (2010) 0.91
An inverse correlation between the apparent rate of dopamine clearance and tonic autoinhibition in subdomains of the rat striatum: a possible role of transporter-mediated dopamine efflux. J Neurochem (2011) 0.91
(3H)-adenosine nucleotide and (3H)-noradrenaline uptake by cold stored guinea-pig taenia caecum; mechanical effects and release of (3H)-adenosine nucleotide by noradrenaline, papaverine, and nitroglycerine. Br J Pharmacol (1973) 0.88
The role of the serotonergic system in locomotor recovery after spinal cord injury. Front Neural Circuits (2015) 0.87
Differential effects of the tricyclic antidepressant amoxapine on glycine uptake mediated by the recombinant GLYT1 and GLYT2 glycine transporters. Br J Pharmacol (2000) 0.87
Structure-activity relations for the inhibition of 5-hydroxytryptamine uptake by tricyclic antidepressants into synaptosomes from serotoninergic neurones in rat brain homogenates. Br J Pharmacol (1974) 0.86
Optodynamic simulation of β-adrenergic receptor signalling. Nat Commun (2015) 0.86
Inhibition of catecholamine uptake in the isolated rat heart by haloalkylamines related to phenoxybenzamine. Br J Pharmacol (1972) 0.86
A subpopulation of outer hair cells possessing GABA receptors with tonotopic organization. Arch Otorhinolaryngol (1989) 0.86
The possible involvement of Na+ ions in corticosterone-induced hypercontractility in the rat anococcygeus muscle. Br J Pharmacol (1976) 0.86
5-HT(1B) autoreceptor regulation of serotonin transporter activity in synaptosomes. Synapse (2012) 0.86
Studies of the interaction of 5-hydroxytryptamine and the perivascular innervation of the guinea-pig caecum. Br J Pharmacol (1972) 0.86
Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UK. Br J Pharmacol (2008) 0.84
Parasympathetic but not sympathetic cardiac dysfunction at early stages of Parkinson's disease. Clin Res Cardiol (2010) 0.83
Degeneration of sympathetic nerves in vitro and development of smooth muscle supersensitivity to noradrenaline. J Physiol (1972) 0.83
Chronic social defeat up-regulates expression of norepinephrine transporter in rat brains. Neurochem Int (2011) 0.83
The effects of cocaine on intracellular Ca2+ handling and myofilament Ca2+ responsiveness of ferret ventricular myocardium. Br J Pharmacol (1990) 0.83
Release of endogenous serotonin from two identified serotonin-containing neurones and the physiological role of serotonin re-uptake. J Physiol (1978) 0.83
Cycling of dense core vesicles involved in somatic exocytosis of serotonin by leech neurons. Front Physiol (2012) 0.82
N-terminal tagging of the dopamine transporter impairs protein expression and trafficking in vivo. Mol Cell Neurosci (2014) 0.81
Bi-directional transport of GABA in human embryonic kidney (HEK-293) cells stably expressing the rat GABA transporter GAT-1. Br J Pharmacol (2002) 0.81
Rotating disk electrode voltammetric measurements of serotonin transporter kinetics in synaptosomes. J Neurosci Methods (2010) 0.81
Cocaine up-regulation of the norepinephrine transporter requires threonine 30 phosphorylation by p38 mitogen-activated protein kinase. J Biol Chem (2011) 0.81
Glycine transport into plasma-membrane vesicles derived from rat brain synaptosomes. Biochem J (1981) 0.81
A novel restricted diffusion model of evoked dopamine. ACS Chem Neurosci (2014) 0.81
Biophysical Approaches to the Study of LeuT, a Prokaryotic Homolog of Neurotransmitter Sodium Symporters. Methods Enzymol (2015) 0.80
Expression and function of variants of human catecholamine transporters lacking the fifth transmembrane region encoded by exon 6. PLoS One (2010) 0.80
C-terminal region regulates the functional expression of human noradrenaline transporter splice variants. Biochem J (2007) 0.80
Regulated norepinephrine transporter interaction with the neurokinin-1 receptor establishes transporter subcellular localization. J Biol Chem (2013) 0.79
Involvement of threonine 258 and serine 259 motif in amphetamine-induced norepinephrine transporter endocytosis. J Neurochem (2010) 0.79
Differential effects of ethanol on glycine uptake mediated by the recombinant GLYT1 and GLYT2 glycine transporters. Br J Pharmacol (2000) 0.79
Dexamethasone-induced up-regulation of the human norepinephrine transporter involves the glucocorticoid receptor and increased binding of C/EBP-β to the proximal promoter of norepinephrine transporter. J Neurochem (2011) 0.78
The effect of narcotic analgesics on the uptake of 5-hydroxytryptamine and (-)-metaraminol by blood platelets. Br J Pharmacol (1973) 0.77
Effects of desipramine treatment on stress-induced up-regulation of norepinephrine transporter expression in rat brains. Psychopharmacology (Berl) (2014) 0.77
Inhibition of high-affinity gamma-aminobutyric acid uptake in primary astrocyte cultures by phorbol esters and phospholipase C. Biochem J (1991) 0.77
Radiotracers for cardiac sympathetic innervation: transport kinetics and binding affinities for the human norepinephrine transporter. Nucl Med Biol (2013) 0.77
Effects of DSP4 on the noradrenergic phenotypes and its potential molecular mechanisms in SH-SY5Y cells. Neurotox Res (2013) 0.77
Autologous transplantation of GDNF-expressing mesenchymal stem cells protects against MPTP-induced damage in cynomolgus monkeys. Sci Rep (2013) 0.77
Diphenyl diselenide decreases the prevalence of vacuous chewing movements induced by fluphenazine in rats. Psychopharmacology (Berl) (2007) 0.76
Differential Internalization Rates and Postendocytic Sorting of the Norepinephrine and Dopamine Transporters Are Controlled by Structural Elements in the N Termini. J Biol Chem (2016) 0.76
Effect of sympathomimetic drugs in eliciting hypertensive responses to reserpine in the rat, after pretreatment with monoamineoxidase inhibitors. Br J Pharmacol (1972) 0.76
Inhibitory action of antidepressants on mouse Betaine/GABA transporter (BGT1) heterologously expressed in cell cultures. Int J Mol Sci (2012) 0.76
Net uptake of gamma-aminobutyric acid by a high-affinity system of rat brain synaptosomes. Proc Natl Acad Sci U S A (1981) 0.76
Imaging of myocardial sympathetic innervation with metaiodobenzylguanidine. J Nucl Cardiol (1998) 0.76
Chemogenetic and Optogenetic Activation of Gαs Signaling in the Basolateral Amygdala Induces Acute and Social Anxiety-Like States. Neuropsychopharmacology (2016) 0.76
Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior. Genes Brain Behav (2013) 0.76
Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system. Psychiatr Genet (2015) 0.76
Proceedings: Drug-induced changes in the sensitivity of the isthmus of rabbit oviduct to noradrenaline. Br J Pharmacol (1974) 0.75
On the functional coupling of neurotransmitter uptake and release in brain. Br J Pharmacol (1976) 0.75
Proceedings: Pinna reflex activated gamma-efferents in the conduction velocity spectrum to hind-limb muscles in the rat. J Physiol (1975) 0.75
Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle. Br J Pharmacol (1990) 0.75
The assessment of potential drug interactions with a new tricyclic antidepressant drug. Br J Clin Pharmacol (1974) 0.75
Neurochemistry and behavior in man. West J Med (1976) 0.75
The discovery of bretylium and bethanidine. Br J Clin Pharmacol (1982) 0.75
Assessment of the interaction between mianserin and centrally-acting antihypertensive drugs. Br J Clin Pharmacol (1983) 0.75
Modulation of gamma-aminobutyric acid transport in nerve endings: role of extracellular gamma-aminobutyric acid and of cationic fluxes. Proc Natl Acad Sci U S A (1978) 0.75
Rapid transcapillary exchange and unidirectional neuronal uptake of noradrenaline in the perfused rabbit heart. J Physiol (1984) 0.75
Role of sialic acid in synaptosomal transport of amino acid transmitters. Proc Natl Acad Sci U S A (1987) 0.75
Membrane Fusion Involved in Neurotransmission: Glimpse from Electron Microscope and Molecular Simulation. Front Mol Neurosci (2017) 0.75
The action of ephedrine. J Physiol (1938) 32.76
The estimation of adrenaline and allied substances in blood. J Physiol (1949) 28.91
The output of sympathetic transmitter from the spleen of the cat. J Physiol (1957) 10.93
The assay of substances from the adrenal medulla. Br J Pharmacol Chemother (1949) 10.29
Stimulus-secretion coupling: the concept and clues from chromaffin and other cells. Br J Pharmacol (1968) 7.91
The release and fate of vaso-active hormones in the circulation. Br J Pharmacol (1969) 7.90
The effect on the intestine of the substance liberated by adrenergic nerves in a rabbit's ear. J Physiol (1939) 6.27
The uptake of [3H]GABA by slices of rat cerebral cortex. J Neurochem (1968) 5.05
Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 4.85
Experiments on liver sympathin. J Physiol (1947) 4.80
THE UPTAKE OF NORADRENALINE BY THE ISOLATED PERFUSED RAT HEART. Br J Pharmacol Chemother (1963) 4.79
Uptake of noradrenaline by adrenergic nerves, smooth muscle and connective tissue in isolated perfused arteries and its correlation with the vasoconstrictor response. Br J Pharmacol Chemother (1968) 3.73
Studies on the uptake of 5-hydroxytryptamine by blood platelets. J Physiol (1959) 3.67
The fate of H3-norepinephrine in animals. J Pharmacol Exp Ther (1961) 3.63
Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol Rev (1966) 3.58
Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain. J Neurochem (1970) 3.42
The role of uptake2 in the extraneuronal metabolism of catecholamines in the isolated rat heart. Br J Pharmacol (1969) 3.25
Inhibition of catecholamine Uptake-2 by steroids in the isolated rat heart. Br J Pharmacol (1970) 3.07
The metabolism of (3H)noradrenaline released by electrical stimulation from the isolated nictitating membrane of the cat and from the vas deferens of the rat. J Physiol (1970) 3.02
A pharmacological study of the depression of spinal neurones by glycine and related amino acids. Exp Brain Res (1968) 2.95
The physiological disposition of H3-epinephrine and its metabolite metanephrine. J Pharmacol Exp Ther (1959) 2.91
The pharmacology of amino acids related to gamma-aminobutyric acid. Pharmacol Rev (1965) 2.81
Metabolism, transfer and storage of 5-hydroxytryptamine in blood platelets. Br J Pharmacol Chemother (1968) 2.74
Mechanism of hydrocortisone potentiation of responses to epinephrine and norepinephrine in rabbit aorta. Circ Res (1969) 2.53
The effect of a saturable uptake mechanism on the slopes of dose-response curves for sympathomimetic amines and on the shifts of dose-response curves produced by a competitive antagonist. J Pharmacol Exp Ther (1969) 2.48
Release of gamma-aminobutyric acid from inhibitory nerves of lobster. Proc Natl Acad Sci U S A (1966) 2.47
EFFECT OF COCAINE, PHENOXYBENZAMINE AND PHENTOLAMINE ON THE CATECHOLAMINE OUTPUT FROM SPLEEN AND ADRENAL MEDULLA. J Pharmacol Exp Ther (1963) 2.31
The extraneuronal uptake and localization of noradrenaline in the cat spleen and the effect on this of some drugs, of cold and of denervation. J Physiol (1970) 2.26
Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake. J Pharmacol Exp Ther (1970) 2.21
Central synaptic transmission--microelectrophoretic studies. Annu Rev Pharmacol (1969) 2.17
The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals. J Pharmacol Exp Ther (1966) 2.03
Regional differences in H3-norepinephrine and H3-dopamine uptake into rat brain homogenates. J Pharmacol Exp Ther (1969) 1.99
The use of some molluscan hearts for the estimation of 5-hydroxytryptamine. Br J Pharmacol Chemother (1955) 1.94
Species and tissue variation in extraneuronal and neuronal accumulation of noradrenaline. J Physiol (1970) 1.93
Steroid potentiation of responses to sympathomimetic amines in aortic strips. Br J Pharmacol (1969) 1.90
The uptake of [14C] choline into synaptosomes in vitro. Biochem J (1968) 1.88
Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action. Science (1969) 1.81
Uptake of 14C glycine by spinal cord. Nature (1969) 1.75
A UNIFIED THEORY OF GLUCOCORTICOID ACTION. Perspect Biol Med (1964) 1.65
Inhibition of motoneurones by iontophoresis of glycine. Nature (1967) 1.65
Serotonin as a possible neurohumoral agent; evidence obtained in lower animals. Ann N Y Acad Sci (1957) 1.63
The uptake of isoprenaline and noradrenaline by the perfused rat heart. Mol Pharmacol (1966) 1.61
Electronmicroscopic localization of 5-hydroxydopamine (3,4,5-trihydroxy-phenyl-ethylamine), a new 'false' sympathetic transmitter. Experientia (1967) 1.61
Glutamate and gamma-aminobutyric acid in brain. Nature (1970) 1.57
THE EFFECT OF SYMPATHETIC NERVE STIMULATION ON VOLUME, VASCULAR RESISTANCE, AND NOREPINEPHRINE OUTPUT IN THE ISOLATED PERFUSED SPLEEN OF THE CAT, AND ITS MODIFICATION BY COCAINE. J Pharmacol Exp Ther (1964) 1.56
An uptake of radioactivity from (plus or minus)-3H-isoprenaline and its inhibition by drugs which potentiate the responses to (minus)-isoprenaline in the guinea-pig isolated trachea. Br J Pharmacol (1969) 1.52
False adrenergic transmitters. Annu Rev Pharmacol (1968) 1.50
Time course of the development of supersensitivity to various amines in the nictitating membrane of the pithed cat after denervation or decentralization. J Pharmacol Exp Ther (1967) 1.48
The distribution of glycine in cat spinal cord and roots. Life Sci (1965) 1.45
Catecholamine uptake by synaptosomes in homogenates of rat brain: stereospecificity in different areas. J Pharmacol Exp Ther (1969) 1.43
Retention of injected catechol amines by the mouse. Br J Pharmacol Chemother (1962) 1.37
Sodium-dependent accumulation of 5-hydroxytryptamine by rat blood platelets. Br J Pharmacol (1969) 1.35
Subcellular distribution of endogenous and (3H) gamma-aminobutyric acid in rat cerebral cortex. J Neurochem (1969) 1.35
Histochemical studies on the uptake of noradrenaline and alpha-methyl-noradrenaline in the perfused rat heart. Eur J Pharmacol (1969) 1.34
Mechanism of amphetamine accumulation in the isolated perfused heart of the rat. J Pharm Pharmacol (1968) 1.30
The inhibition of human platelet 5-hydroxytryptamine uptake by tricyclic antidepressive drugs. The relation between structure and potency. J Pharm Pharmacol (1969) 1.27
5-hydroxytryptamine uptake by rat brain in vitro. Life Sci (1967) 1.21
Histochemical fluorescence studies on noradrenaline accumulation by Uptake 2 in the isolated rat heart. Br J Pharmacol (1969) 1.20
The metabolism of gamma-aminobutyric acid (GABA) in the lobster nervous system--uptake of GABA in the nerve-muscle preparations. J Neurochem (1968) 1.19
Autonomic nervous system: newer mechanisms of adrenergic blockade. Annu Rev Pharmacol (1966) 1.15
Quantitative studies of norepinephrine uptake by synaptosomes. Biochem Pharmacol (1968) 1.11
Effects of 6-hydroxydopamine on the uptake and storage of noradrenaline in sympathetic adrenergic neurons. Eur J Pharmacol (1970) 1.09
Intraneuronal and extraneuronal accumulation of sympathomimetic amines in the isolated nictitating membrane of the cat. J Pharmacol Exp Ther (1970) 1.08
The density of adrenergic innervation of the cat's nictitating membrane as a factor influencing the sensitivity of the isolated preparation to l-norepinephrine. J Pharmacol Exp Ther (1969) 1.07
The role of internal and external Na+ and K+ on the uptake of [3H] noradrenaline by synaptosomes prepared from rat brain. Biochim Biophys Acta (1970) 1.06
Accumulation of tritiated 5-hydroxytryptamine in brain slices. Life Sci (1967) 1.06
[EFFECTS OF PHENOXYBENZAMINE, PHENTOLAMINE AND AZAPETINE ON ADRENERGIC SYNAPSES OF THE CAT SPLEEN. BLOCKADE OF ALPHA-ADRENERGIC RECEPTORS AND INHIBITION OF RE-UPTAKE OF NEURALLY RELEASED NORADRENALINE]. Helv Physiol Pharmacol Acta (1964) 1.05
The uptake, storage, release and metabolism of noradrenaline in sympathetic nerves. Prog Brain Res (1969) 1.03
A CARRIER-MEDIATED TRANSFER MODEL FOR THE ACCUMULATION OF 14-C-GAMMA-AMINOBUTYRIC ACID BY SUBCELLULAR BRAIN PARTICLES. Biochem Pharmacol (1965) 1.02
CNS at the cellular level: identity of transmitter agents. Annu Rev Physiol (1970) 1.01
Metabolism of norepinephrine in the central nervous system. Pharmacol Rev (1966) 1.00
RADIOAUTOGRAPHIC STUDIES OF BINDING OF GAMMA-AMINOBUTYRIC ACID TO THE ABDOMINAL STRETCH RECEPTORS OF THE CRAYFISH. Biochem Pharmacol (1964) 0.96
The autonomic nervous system. Annu Rev Pharmacol (1967) 0.91
The uptake of l- and d-norepinephrine by the isolated perfused rabbit heart in relation to the stereospecificity of the sensitizing action of cocaine. J Pharmacol Exp Ther (1968) 0.91
Evidence for an excitatory transmitter role of serotonin in molluscan central synapses. Adv Pharmacol (1968) 0.90
Adrenaline and noradrenaline. Vitam Horm (1957) 0.90
Uptake of acetylcholine in rat brain cortex slices. Biochem Pharmacol (1969) 0.89
Accumulation of alpha-methyltyramine by the noradrenaline uptake process in the isolated rat heart. J Pharm Pharmacol (1966) 0.84
Further studies on the binding of gamma-aminobutyric acid by brain. Can J Biochem (1967) 0.83
The pharmacology of spinal postsynaptic inhibition. Prog Brain Res (1969) 0.82
[On the mechanism of potentiation of catecholamine action following chronic postganglionic sympathetic denervation]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1967) 0.79
Stimulation-induced release of serotonin. Adv Pharmacol (1968) 0.78
Regional studies of catecholamines in the rat brain. I. The disposition of [3H]norepinephrine, [3H]dopamine and [3H]dopa in various regions of the brain. J Neurochem (1966) 7.91
The uptake of [3H]GABA by slices of rat cerebral cortex. J Neurochem (1968) 5.05
The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci U S A (1986) 3.97
Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain. J Neurochem (1970) 3.42
The role of uptake2 in the extraneuronal metabolism of catecholamines in the isolated rat heart. Br J Pharmacol (1969) 3.25
Inhibition of catecholamine Uptake-2 by steroids in the isolated rat heart. Br J Pharmacol (1970) 3.07
Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature (1977) 2.74
The retrograde axonal transport of nerve growth factor. Brain Res (1974) 2.60
Release of gamma-aminobutyric acid from inhibitory nerves of lobster. Proc Natl Acad Sci U S A (1966) 2.47
Multiple opiate receptor sites on primary afferent fibres. Nature (1980) 2.34
The possible existence of multiple receptors for substance P. Naunyn Schmiedebergs Arch Pharmacol (1982) 2.18
The physiologic disposition and metabolism of norepinephrine in immunosympathectomized animals. J Pharmacol Exp Ther (1966) 2.03
GABA uptake in rat central nervous system: comparison of uptake in slices and homogenates and the effects of some inhibitors. J Neurochem (1971) 2.00
Trans-synaptic regulation of growth and development of adrenergic neurones in a mouse sympathetic ganglion. Brain Res (1971) 1.99
7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc Natl Acad Sci U S A (1988) 1.99
Release of dopamine from dendrites in rat substantia nigra. Nature (1976) 1.95
Reduced uptake of tritiated noradrenaline in tissues of immunosympathectomized animals. Nature (1965) 1.91
Autoradiographic localization of 3 H-GABA in rat retina. Nat New Biol (1972) 1.90
Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens. Br J Pharmacol (1969) 1.90
Multiple tachykinin binding sites in peripheral tissues and in brain. Eur J Pharmacol (1986) 1.86
Catecholamine uptake processes. Br Med Bull (1973) 1.83
Uptake and metabolism of gamma-aminobutyric acid by neurones and glial cells. Biochem Pharmacol (1975) 1.83
The inhibition of noradrenaline uptake by drugs. Adv Drug Res (1965) 1.82
Use of catechol O-methyltransferase for the enzyme radiochemical assay of dopamine. J Neurochem (1973) 1.82
Capsaicin-induced depletion of substance P from primary sensory neurones. Brain Res (1978) 1.80
Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death. Proc Natl Acad Sci U S A (1994) 1.79
Dopamine receptors in the brain. Science (1975) 1.79
Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J (Clin Res Ed) (1984) 1.78
Uptake mechanisms for neurotransmitter amines. Biochem Pharmacol (1974) 1.73
Tissue selectivity of substance P alkyl esters: suggesting multiple receptors. Eur J Pharmacol (1983) 1.65
Sodium dependence of transmitter uptake at adrenergic nerve terminals. Mol Pharmacol (1966) 1.63
A post-mortem study of the cholinergic and GABA systems in senile dementia. Brain (1982) 1.62
The release of gamma-aminobutyric acid during inhibition in the cat visual cortex. J Physiol (1971) 1.59
Uptake, storage and metabolism of norepinephrine in tissues of the developing rat. J Pharmacol Exp Ther (1967) 1.58
Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain (1974) 1.57
Differences in the regulation of tyrosine hydroxylase and dopa decarboxylase in sympathetic ganglia and adrenals. Nat New Biol (1971) 1.54
Another mechanism for creating diversity in gamma-aminobutyrate type A receptors: RNA splicing directs expression of two forms of gamma 2 phosphorylation site. Proc Natl Acad Sci U S A (1990) 1.53
Biochemical and anatomical observations on the degeneration of peptide-containing primary afferent neurons after neonatal capsaicin. Neuroscience (1981) 1.50
A quantitative ultrastructural and biochemical analysis of the process of reinnervation of the superior cervical ganglion in the adult rat. Brain Res (1974) 1.43
Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies. Eur J Pharmacol (1978) 1.38
Smoking...harmful to the brain. Nature (1996) 1.37
Enhancement of H-3-norepinephrine uptake in rat tissues by O-methylated metabolites of catecholamines. J Pharmacol Exp Ther (1966) 1.36
Subcellular distribution of endogenous and (3H) gamma-aminobutyric acid in rat cerebral cortex. J Neurochem (1969) 1.35
The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart. J Pharmacol Exp Ther (1965) 1.30
Effects of surgical decentralization and nerve growth factor on the maturation of adrenergic neurons in a mouse sympathetic ganglion. J Neurochem (1972) 1.28
Glycine uptake in rat central nervous system slices and homogenates: evidence for different uptake systems in spinal cord and cerebral cortex. J Neurochem (1971) 1.24
Release and metabolism of substance P in rat hypothalamus. Nature (1976) 1.24
Regional studies of catecholamines in the rat brain. II. Rate of turnover of catecholamines in various brain regions. J Neurochem (1966) 1.23
Purification and characterisation of a membrane-bound substance-P-degrading enzyme from human brain. Eur J Biochem (1981) 1.22
Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Neurosci Lett (1980) 1.21
Calcium-dependent release of somatostatin and neurotensin from rat brain in vitro. Nature (1978) 1.21
Effects of 6-hydroxydopamine on noradrenaline-containing neurones in the rat brain. Nature (1969) 1.20
Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype. Proc Natl Acad Sci U S A (1992) 1.19
The metabolism of gamma-aminobutyric acid (GABA) in the lobster nervous system--uptake of GABA in the nerve-muscle preparations. J Neurochem (1968) 1.19
Dose-dependent effects of capsaicin on primary sensory neurons in the neonatal rat. J Neurosci (1983) 1.18
Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. J Pharmacol Exp Ther (1966) 1.18
Mechanism of inositol monophosphatase, the putative target of lithium therapy. Proc Natl Acad Sci U S A (1994) 1.18
Studies of the uptake of 3 H-gaba and ( 3 H)glycine in slices and homogenates of rat brain and spinal cord by electron microscopic autoradiography. Brain Res (1972) 1.18
Localizing 3H-GABA in nerve terminals of rat cerebral cortex by electron microscopic autoradiography. Nature (1971) 1.18
Noradrenaline metabolizing enzymes in normal and sympathetically denervated vas deferens. J Neurochem (1971) 1.12
The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. J Med Chem (1994) 1.12
Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's type. Neurosci Lett (1983) 1.12
A quantitative comparison of the formation of synapses in the rat superior cervical sympathetic ganglion by its own and by foreign nerve fibres. Brain Res (1976) 1.10
The role of post-synaptic neurones in the biochemical maturation of presynaptic cholinergic nerve terminals in a mouse sympathetic ganglion. J Physiol (1972) 1.10
Effects of protriptyline on the depletion of catecholamines induced by 6-hydroxydopamine in the brain of the rat. J Pharm Pharmacol (1970) 1.10
Release of (3H)gamma-aminobutyric acid from glial cells in rat dorsal root ganglia. J Neurochem (1974) 1.09
The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: A novel catechol amine uptake process. Br J Pharmacol Chemother (1965) 1.08
Synaptosomes: different populations storing catecholamines and gamma-aminobutyric acid in homogenates of rat brain. Nature (1968) 1.08
Dopamine selectively increases 3H-GABA release from slices of rat substantia nigra in vitro. Nature (1977) 1.08
Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease. Alzheimer Dis Assoc Disord (1987) 1.06
Trans-synaptic regulation of tyrosine hydroxylase activity in adrenergic neurones: effect of potassium concentration on cultured sympathetic ganglia. Naunyn Schmiedebergs Arch Pharmacol (1972) 1.06
The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes. Neurosci Lett (1982) 1.05
Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: the NMS/Oxo-M ratio as an index of efficacy at cortical muscarinic receptors. Br J Pharmacol (1988) 1.05
Neuronal uptake processes for amines and amino acids. Adv Biochem Psychopharmacol (1970) 1.05
Thermoregulation: effects of environmental temperature on turnover of hypothalamic norepinephrine. Science (1969) 1.03
Modification of an enzyme radiochemical assay procedure for noradrenaline. Biochem Pharmacol (1970) 1.02
Catecholamine-sensitive adenylate cyclases in nervous tissues. J Neurochem (1977) 1.02
Differences in the uptake, storage and metabolism of (+)- and (-)-noradrenaline. Br J Pharmacol (1971) 1.02
Effect of chlorpromazine and some of its metabolites on the dopamine-sensitive adenylate cyclase of rat brain striatum. J Pharm Pharmacol (1974) 1.02
Substance P. J Med Chem (1982) 1.01
Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum. Mol Pharmacol (1976) 1.00
Inhibition of the extraneuronal metabolism of noradrenaline in the isolated heart by adrenergic blocking agents. Nature (1967) 1.00
Release of enkephalin from rat globus pallidus in vitro. Nature (1978) 1.00
Stimulation of a dopamine-sensitive adenylate cyclase in homogenates of rat striatum by a metabolite of piribedil (ET 495). Naunyn Schmiedebergs Arch Pharmacol (1974) 1.00
Substance P: localization in synaptic vesicles in rat central nervous system. J Neurochem (1977) 0.99
Monoamine oxidase and catechol-O-methyl transferase activities in cat nictitating membrane and rat and guinea-pig vas deferens after sympathectomy. Br J Pharmacol (1968) 0.99
Muscarinic cholinergic receptors in rat corpus striatum and regulation of guanosine cyclic 3',5'-monophosphate. Mol Pharmacol (1978) 0.99
Vasoactive intestinal polypeptide (VIP): vesicular localization and potassium evoked release from rat hypothalamus. Brain Res (1978) 0.99
Vasopressin, oxytocin and neurophysins in the human brain and spinal cord. Brain Res (1984) 0.98
Characteristics of noradrenaline uptake in the iris ciliary body and other peripheral tissues of the rat. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1968) 0.98
Reduced glutamic-acid-decarboxylase activity of post-mortem brain in Huntington's chorea. Lancet (1973) 0.98
The Ferrier Lecture, 1983. Amino acids and peptides: fast and slow chemical signals in the nervous system? Proc R Soc Lond B Biol Sci (1984) 0.98
Calcitonin gene-related peptide: novel neuropeptide. Life Sci (1986) 0.97
Use of ADTN to define specific 3H-spirerone binding to receptors in brain. Nature (1978) 0.97
Enantiomers of HA-966 (3-amino-1-hydroxypyrrolid-2-one) exhibit distinct central nervous system effects: (+)-HA-966 is a selective glycine/N-methyl-D-aspartate receptor antagonist, but (-)-HA-966 is a potent gamma-butyrolactone-like sedative. Proc Natl Acad Sci U S A (1990) 0.96
Increased brain dopamine and dopamine receptors in schizophrenia. Arch Gen Psychiatry (1982) 0.96
Dopamine receptors in the retina may all be linked to adenylate cyclase. Nature (1979) 0.96
Selective extraction of small and large molecules from the cerebrospinal fluid by Purkinje neurons. Science (1985) 0.96
Correlation of cortical cholinergic and GABA deficits with quantitative neuropathological findings in senile dementia. Brain (1984) 0.95
The interaction between MK-801 and receptors for N-methyl-D-aspartate: functional consequences. Neuropharmacology (1987) 0.95